Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SS Innovations International ( (SSII) ) has issued an update.
On June 3, 2025, SS Innovations International will ring the opening bell at Nasdaq MarketSite in New York City, marking a significant milestone following the April 2025 uplisting of its common stock to Nasdaq. This event also celebrates the successful completion of over 4,000 robotic surgeries using the SSi Mantra system without complications, highlighting its growing acceptance in India and six other countries, with plans to expand into the European Union and the United States.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Underperform.
SS Innovations International’s overall score is primarily impacted by its financial performance and valuation challenges due to unprofitability and high leverage. Technical analysis reveals bearish trends, further weighing down the score. However, strong operational achievements and growth prospects offer some positive outlook.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. (Nasdaq: SSII) is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. The company offers the proprietary ‘SSi Mantra’ surgical robotic system and ‘SSi Mudra’ surgical instruments, supporting a variety of procedures including robotic cardiac surgery. Headquartered in India, SS Innovations plans to expand its presence with cost-effective and advanced robotic solutions.
Average Trading Volume: 49,587
Technical Sentiment Signal: Sell
Current Market Cap: $1.23B
For an in-depth examination of SSII stock, go to TipRanks’ Stock Analysis page.